Ligand Pharmaceuticals | LGND - بدهکاران تجاری





بدهکاران تجاری تغییر دادن تاریخ
Agenus USD 22.44M 1.14M 2025-12
Amgen USD 9.57B 1.08B 2025-12
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Baxter International USD 2.01B 231M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Eli Lilly USD 19.46B 2.25B 2025-09
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Enviri Corporation USD 341.34M 27.84M 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Glaxosmithkline GBP 10.45B 707.81M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 140.86M 75.6M 2025-12
Intrexon USD 1.02M 559K 2024-06
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
MacroGenics USD 13.37M 55.86M 2025-12
Merck USD 12.12B 596M 2025-09
Pacira USD 124.07M 8.8M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Veracyte USD 44.66M 3.17M 2025-12